News
Results from two Phase III studies of KX2-391, also known as KX-01 ointment, in the treatment of actinic kera…
St. Louis dermatologist George J. Hruza, MD, MBA, FAAD, is set to begin his one-year term as president of the American A…
Cutera, Inc. has launched its excel V+ laser platform, which the company describes as a technological advancement that i…
Sentient Lasers has launched its new, Dot Demo service. The Dot Demo service provides customers with a live vi…
After Psoriasis: Treatment Effects on Comorbidities
Treating psoriasis with biologic drugs can reduce the early plaqu…
When I think of San Francisco dermatologist Vic Narurkar, MD, I don’t think of all of his professional accomplishm…
Jeuveau from Evolus Now FDA Cleared for Aesthetic Injection
The FDA has approved Jeuveau (prabotulinumtoxinA-xvfs) fr…
Topline results from the pivotal trial of Sienna Biopharmaceuticals’ SNA-001 show that the topical agent in conjun…
